The molecular mechanism of cell cycle arrest also involves the downregulation of cyclin D1 and CDK4 complex in B cell malignancies, bladder cancer, melanoma, and HepG2 hepatocarcinoma cell lines [19,54,55,62]. This evidence concerns the gene CDK4 and urinary bladder carcinoma.